Nanopore direct RNA sequencing reveals METTL2A-mediated m 3 C sites in poly(A) RNA
Genome Research · 2025
DOI: 10.1101/gr.280269.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2025. Verfasst von Shuhei Mitsutomi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Isotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Methyltransferases, RNA, Messenger, Poly A. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science, JSPS, Takeda Science Foundation.
Abstract (Originalsprache)
RNA modifications play critical roles in cellular homeostasis and development by regulating gene expression, RNA metabolism, and translation. Their dysregulation contributes to the development of human diseases, including cancer. 3-methylcytidine (m 3 C) primarily occurs in transfer RNA, where it regulates translation, stem cell pluripotency, and mitochondrial function. m 3 C has also been detected in polyadenylated (poly[A]) RNA by mass spectrometric analysis; however, its transcriptome-wide distribution and functions remain unknown because of its low abundance and technical challenges. Here, we show that METTL2A , an m 3 C writer, is upregulated and associated with poor prognosis in pancreatic cancer tumors, while also being essential for pancreatic cancer cell proliferation. Using comparative nanopore direct RNA sequencing, we identify potential METTL2A-mediated m 3 C sites in poly(A) RNA. These m 3 C sites are mapped in both messenger RNA and mitochondrial RNA and are enriched in the CC motif and coding sequences. METTL2A knockdown alters expression of S100A4 mRNA isoforms, which contains METTL2A-mediated m 3 C sites. Notably, many transcripts with METTL2A-mediated m 3 C sites are upregulated upon METTL2A knockdown. We reveal the transcriptome-wide presence of m 3 C sites in poly(A) RNA and suggest their potential roles in regulating gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Isotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
- Research Institute, National Cancer Center, Tokyo, 104-0045, Japan.
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, 277-8561, Japan.
- Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, 078-8510, Japan.
- Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
- Isotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan; akimitsu@ric.u-tokyo.ac.jp kenzui@ric.u-tokyo.ac.jp.
ORCID-Profile: Shuhei Mitsutomi, Masahide Seki, Kenzui Taniue, Nobuyoshi Akimitsu
Förderung
- Japan Society for the Promotion of Science
- JSPS
- Takeda Science Foundation
- Uehara Memorial Foundation
- Life Science Foundation
- the Kobayashi Foundation
- the Naito Foundation
Zitieren
APA
Mitsutomi, S., Sugawara, A., Seki, M., Suzuki, Y., Miyao, S., Du, H., Takahashi, K., Mizukami, Y., Taniue, K., & Akimitsu, N. (2025). Nanopore direct RNA sequencing reveals METTL2A-mediated m 3 C sites in poly(A) RNA. Genome Research. https://doi.org/10.1101/gr.280269.124
Vancouver
Mitsutomi S, Sugawara A, Seki M, Suzuki Y, Miyao S, Du H, et al. Nanopore direct RNA sequencing reveals METTL2A-mediated m 3 C sites in poly(A) RNA. Genome Research. 2025. doi:10.1101/gr.280269.124
BibTeX
@article{Mitsutomi2025,
author = {Mitsutomi, Shuhei and Sugawara, Anzu and Seki, Masahide and Suzuki, Yutaka and Miyao, Sotaro and Du, Haozhe and Takahashi, Kenji and Mizukami, Yusuke and Taniue, Kenzui and Akimitsu, Nobuyoshi},
title = {Nanopore direct RNA sequencing reveals METTL2A-mediated m 3 C sites in poly(A) RNA},
journal = {Genome Research},
year = {2025},
doi = {10.1101/gr.280269.124}
}
EUVIMED